Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 ,inter alia, to consider and approve Intimitation of Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has informed BSE that its Board of Directors will meet on Thursday, 16 October 2025 at 3:00 PM. Key agenda items include the appointment of CA. Yash Jain as internal auditor, Mr. Yogesh Prakash Supekar as Additional Non-Executive Director, and Mr. Rishi Upadhaya as Company Secretary and Compliance Officer, along with other routine agenda items. The filing also notes that the trading window for insiders remains closed until 48 hours after the company declares its Un-Audited Financial Results for the quarter and half-year ended 30 September 2025.
This is a routine advance intimation of a board meeting with no financial numbers or major corporate action disclosed yet. Shareholders should watch for the outcomes of the board meeting on 16 October, particularly the appointment of key managerial personnel, and the upcoming Q2/H1 FY26 results declaration.